Belite Bio (BLTE) Company Overview

Profile

Full Name:

Belite Bio, Inc

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

April 29, 2022

Indexes:

Not included

Description:

Belite Bio is a biotechnology company focused on developing innovative treatments for eye diseases and metabolic disorders. They aim to improve patients' quality of life through advanced research and new therapies, particularly in areas like retinitis pigmentosa and other retinal diseases.

Events Calendar

Earnings

Next earnings date:

Mar 12, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 12, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 21, 25 Benchmark
Buy
Nov 15, 24 Maxim Group
Buy
Nov 13, 24 HC Wainwright & Co.
Buy
Sep 12, 24 HC Wainwright & Co.
Buy
Aug 13, 24 HC Wainwright & Co.
Buy
Aug 13, 24 Benchmark
Buy
Jun 20, 24 Cantor Fitzgerald
Overweight
Jun 13, 24 HC Wainwright & Co.
Buy
May 16, 24 Benchmark
Buy
May 15, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Belite Bio?
  • Does Belite Bio pay dividends?
  • What sector is Belite Bio in?
  • What industry is Belite Bio in?
  • What country is Belite Bio based in?
  • When did Belite Bio go public?
  • Is Belite Bio in the S&P 500?
  • Is Belite Bio in the NASDAQ 100?
  • Is Belite Bio in the Dow Jones?
  • When was Belite Bio's last earnings report?
  • When does Belite Bio report earnings?
  • Should I buy Belite Bio stock now?

What is the ticker symbol for Belite Bio?

The ticker symbol for Belite Bio is NASDAQ:BLTE

Does Belite Bio pay dividends?

No, Belite Bio does not pay dividends

What sector is Belite Bio in?

Belite Bio is in the Healthcare sector

What industry is Belite Bio in?

Belite Bio is in the Biotechnology industry

What country is Belite Bio based in?

Belite Bio is headquartered in United States

When did Belite Bio go public?

Belite Bio's initial public offering (IPO) was on April 29, 2022

Is Belite Bio in the S&P 500?

No, Belite Bio is not included in the S&P 500 index

Is Belite Bio in the NASDAQ 100?

No, Belite Bio is not included in the NASDAQ 100 index

Is Belite Bio in the Dow Jones?

No, Belite Bio is not included in the Dow Jones index

When was Belite Bio's last earnings report?

Belite Bio's most recent earnings report was on Nov 12, 2024

When does Belite Bio report earnings?

The next expected earnings date for Belite Bio is Mar 12, 2025

Should I buy Belite Bio stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions